Facebook
Twitter
LinkedIn
Forward2022 Summit on Cancer Health Disparities
Learning Objectives
At the conclusion of the activity, participants will be able to:
- Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
- State the financial and physical barriers, review strategies to navigate these factors to optimize management of patients with cancer.
- Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
- Describe challenges and develop novel approaches to improve participation of underrepresented communities in clinical trials.
ABSTRACT SUBMISSION INFORMATION
ABSTRACT SUBMISSION DEADLINE: January 10, 2022 11:59 PM Pacific Time
We will accept abstracts in the following categories.
Please select a category that fits the submission best when submitting the abstract.
- Technology
- Tumor biology
- Precision oncology
- Epidemiology
- Screening
- Health policy
- Survivorship
- Quality improvement
- Database analysis
- Encore abstracts: The abstract committee will accept encore clinical trials abstracts for this conference. Submissions with additional data that supplement the previous presentation will be preferred. Authors should provide information regarding the original presentation, including the name of the meeting where the abstract was originally presented.
Conference Chairs: David Aboulafia, MD, Edith P. Mitchell, MD, and Hannah Linden, MD, FACP
All times listed below are in Pacific Standard Time.
April 29, 2022
2 PM to 3 PM - Registration/Check-in, Exhibits
3:00 PM – 3:15 PM PST: Welcome
Session 1: 3:15 PM – 4:15 PM PST: Access to insurance and cancer disparities
Moderator: Hannah Linden, MD, FACP
3:15 - 3:30 PM PST: Access to insurance and access to cancer care - Amy Davidoff, PhD, MS
3:30 - 3:45 PM PST: ACA and access to cancer care - J. Richard Goss, MD, MPH, FACP
3:45 - 4:00 PM PST: Experience from a county hospital - Hannah Linden, MD, FACP
4:00 - 4:15 PM PST: Panel discussion / Q&A
Session 2: 4:15 PM – 5:15 PM PST: Cancer care disparities – training the next generation
Moderator: Chandrikha Chandrasekharan, MBBS
4:15 - 4:25 PM PST: Career in cancer care disparities - Narjust Duma, MD
4:25 - 4:35 PM PST: Funding opportunities for disparities research - Edith Mitchell, MD
4:35 - 5:15 PM PST: Panel discussion - Manali Indravadan Patel, MD, MPH, MS, Molly Tokaz, MD, Lisa Tachiki, MD
5:15 PM to 6:30 PM PST: Roundtable discussion - Access to care by practice setting
Moderator: Rachna Shroff, MD
Keynote Speech: Ana Maria Lopez, MD, MPH, MACP, FRCP
Panelists: Shailender Bhatia, MD, Joseph Rosales, MD, Michael Wagner, MD, Sibel Blau, MD
April 30, 2022
Session 1: 08:00 AM to 09:45 AM PST: Technology and cancer disparities
Moderator: Jack West, MD
8:00 - 8:15 AM PST: Telemedicine for cancer care after the COVID-19 pandemic: lessons learned - Jack West, MD
8:15 - 8:30 AM PST: Mitigating disparities potentially magnified by telemedicine: Addressing "Techquity" - Joy Feliciano, MD
8:30 - 8:45 AM PST: Project ECHO and delivering global oncology - Ellen Baker, MD, MPH
8:45 - 9:00 AM PST: Panel discussion, Q/A on telemedicine addressing or worsening disparities
9:00 - 9:15 AM PST: Asynchronous integration of an oncology subspecialist with local delivery of cancer care: The AccessHope experience - Afsaneh Barzi, MD, PhD
9:15 - 9:30 AM PST: Virtual tumor boards to bring subspecialist care beyond tertiary care centers - Ghassan Abou-Alfa, MD, MBA
9:30 - 9:45 AM PST: Panel discussion, Q/A on models for overcoming geographic barriers to increasingly complex oncology delivery
9:45 - 10:15 AM PST: Break
Session 2: 10:15 AM to 12:00 PM PST: Breast Cancer Disparities Session – sponsored by BCRF
Moderator: Julie Gralow, MD
10:15 - 10:30 AM PST: Lancet Commission on Women and Cancer - Ophira Ginsburg, MD
10:30 - 10:45 AM PST: WHO Global Breast Cancer Initiative - Ben Anderson, MD
10:45 - 11:00 AM PST: Overcoming Racial, Ethnic, and Socioeconomic Disparities in Breast Cancer Care in the US - Edith Mitchell, MD
11:00 - 11:15 AM PST: University of Washington Equity Initiative - Rachel Yung, MD
11:15 - 12:00 PM PST: Panel Discussion - Bridgette Hempstead
12:00 - 01:00 PM PST: Lunch
Session 3: 1:00 PM to 2:15 PM PST: Professional Societies’ initiatives in improving cancer health disparities
Moderator: Edith Mitchell, MD
1:00 - 1:30 PM PST: Society President or representative presentations
- ASCO's efforts in improving access to cancer care - Everett Vokes, MD, FASCO
- ASCP's efforts in improving access to cancer care - Danny A. Milner, Jr, MD, MSc(Epi), FASCP
- EONS' efforts in improving access to cancer care - Johan deMunter, EONS President
- ASTRO’S efforts in improving access to cancer care – Geraldine Jacobson, MD, MPH, MBA, FASTRO
- NCCN'S efforts in improving access to cancer care - Robert W. Carlson, MD
1:30 - 2:15 PM PST: Panel discussion
2:15 PM to 2:45 PM PST: Break
Session 4: 2:45 PM to 4:15 PM PST: Cancer Health Disparities in the LGBTQ population
Moderator: David Aboulafia, MD
2:45 - 3:05 PM PST: Anal cancer screening among people living with HIV: Lessons from the ANCHOR study - Joel Palefsky, MD
3:05 - 3:25 PM PST: Cultural barriers to equity and cancer disparities among sexual and gender minorities - Matthew Schabath, PhD
3:25 - 3:45 PM PST: Cancer screening among women living with HIV - Liz Chiao, MD
3:45 - 4:15 PM PST: Panel discussion - Bakari Salim AIDS Malignancy Community Global CAB and Michael Louella, University of Washington AIDS Clinical Trial Unit Outreach Coordinator
6:00 - 9:00 PM PST: Gala dinner
May 01, 2022
Session 1: 8:00 AM to 9:15 AM PST: Global Oncology
Moderators: Aparna Parikh, MD, MS & Bhawna Sirohi, MBBS, FRCP
8:00 - 8:15 AM PST: The promise of Universal Health Coverage (UHC) for global cancer: moving from challenges to solutions - Professor Richard Sullivan, PhD
8:15 - 8:30 AM PST: Levelling the field in cancer research to control global cancer burden - Nazik Hammad, MD, MSc, MEHP, FACP
8:30 - 8:45 AM PST: Founding of cancer care and research institute in Jamaica - Dingle Spence, BSc, MBBS, DMRT, Dip Pall. Med, FRCR
8:45 - 9:15 AM PST: Panel discussion - Manoj P. Menon, MD, MPH
9:15 - 9:45 AM PST: Break & Abstract Session 1
9:15 - 9:21 AM - Poster:
- A Global Community Advisory Board (GCAB) to enhance clinical research studies in the AIDS Malignancy Consortium (AMC)
- An Evaluation of Health Disparities Among Breast Cancer Patients and the Relationship to Emergency Department Utilization
9:21 - 9:27 AM - Poster:
- A Methodology to Quality Improvement in Patient Navigation, Access to Care, and Patient Education in Rural and Urban Cancer Centers
- Addressing Latinx CANcer Care Equity (ALCANCE) Randomized Controlled Trial: baseline findings from a community health worker led intervention
9:27 - 9:33 AM - Poster:
- COMPARISON OF SET-UP ERRORS IN CONFORMAL RADIOTHERAPY OF CARCINOMA CERVIX USING DIFFERENT IMMOBILIZATION TECHNIQUES- A PROSPECTIVE STUDY FROM A TERTIARY CARE HOSPITAL IN EASTERN INDIA
- Factors affecting utilization of chemotherapy in Acute Lymphoblastic Leukemia (ALL): A SEER database study
9:33 - 9:39 AM - Poster:
- Healthcare Costs and Financial Barriers to Diagnosis and Treatment of People Living with HIV-Associated Kaposi’s Sarcoma in Western Kenya: A Qualitative Analysis
- FACTORS INFLUENCING THE ACCEPTANCE OF BREAST CONSERVING SURGERY IN EARLY BREAST CANCER PATIENTS IN RURAL SOUTHERN INDIA - A PROSPECTIVE STUDY
9:39 - 9:45 AM - Poster:
- Stigma in the Diagnosis and Treatment of HIV-associated Kaposi's Sarcoma
- Barriers and facilitators to genomic testing uptake and cancer clinical trial enrollment in historically underrepresented patient populations – Clinician and research staff perceptions
Session 2: 9:45 - 11:00 AM PST: Clinical Trials and Disparities in cancer care
Moderator: Chadi Nabhan, MD, MBA, FACP
9:45 - 10:00 AM PST: Keynote speech - Joseph Unger, PhD, MS
10:00 - 11:00 AM PST: Panel discussion - Mark Pegram, MD, Shilpen Patel, MD, Mark Lewis, MD
Session 3: 11:05 AM to 12:05 PM PST: Precision oncology/cellular therapies and cancer disparities
Moderator: Vivek Subbiah, MD
11:05 - 11:15 AM PST: Globalization of Precision Oncology: Future outlook and challenges - Vivek Subbiah, MD
11:15 - 11:25 AM PST: Implementation of Precision medicine in Lung Cancer: Challenges - Rafael Santana-Davila, MD
11:25 - 11:35 AM PST: Precision Medicine in Bladder Cancer: Challenges and opportunities - Petros Grivas, MD, PhD
11:35 - 11:45 AM PST: Health Economics of Precision Oncology - Dipesh Uprety, MD
11:45 - 11:55 AM PST: Genetics and high risk hereditary cancers and Precision Medicine: Challenges - Marianne Dubard-Gault, MD, MS
11:55 - 12:05 AM PST: Q&A
12:05 - 01:00 PM PST: Lunch & Abstract Session 2
12:05 - 12:15PM - Oral:
- Disparities in breast cancer genomic signature ordering practices in the United States
12:15 - 12:25 PM - Oral:
- National Coalition for Cancer Survivorship's State of Survivorship Survey: Disparities in Quality of Care
12:25 - 12:35 PM - Oral:
- Assessing disparities in social determinants of health between Hispanics/LatinX and Non-Hispanic Whites
12:35 - 12:41 PM - Poster:
- Barriers and facilitators to genomic testing uptake and cancer clinical trial enrollment in historically underrepresented patient populations – Clinician and research staff perceptions
- Delaying Filgrastim Administration after Autologous Stem Cell Transplant in Patients with Multiple Myeloma
12:41 - 12:47 PM- Poster:
- Disparity of race reporting and representation among US FDA approved tyrosine kinase inhibitors
- EVALUATION OF THE PALLIATIVE PROGNOSTIC INDEX (PPI) IN CANCER PATIENTS
12:47 - 12:53 PM - Poster:
- Predict score and luminal localized breast cancer in young women
- Epidemiological and clinical characteristics of male breast cancer in the southern of Tunisia: A single center experience
Session 4: 1:00 - 2:00 PM PST: Plenary lecture - Expediting adoption of practice-changing research in community practice - current challenges and potential solutions
Moderator: Shaji Kumar, MD
Plenary Speaker 1:
Introduction: Natasha Hunter, MD
Speaker: Nancy E. Davidson, MD
Plenary Speaker 2:
Introduction: Aparna Parikh, MD, MS
Speaker: Wui-Jin Koh, MD
Panelists: Edward L. Briercheck, MD, Tony Blau, MD
2:00 - 2:15 PM PST: Break
Session 5: 2:15 - 3:30 PM PST: Imaging in LMIC
Moderator: Saurabh Jha, MD
Panelists: Farouk Dako, MD, MPH, Ravi Shrestha, PhD, Chiranjiv Singh, Norissa Haynes, MD, MPH
Hotel Room Reservation
A limited number of rooms have been reserved for the attendees of this conference at the Grand Hyatt Seattle at the discounted rates listed below. All reservations must be made by Friday, April 8, 2022 to receive the discounted rate. Please follow the link below to reserve your room: https://www.hyatt.com/en-US/group-booking/SEAGH/G-BINY
Name changes on, or other transfers of, room reservations will not be accepted after the Cut-Off Date. The Guest Room Rates are quoted exclusive of any applicable taxes taxes (which are currently 15.7% and $2 nightly Seattle Tourism Assessment Fee) applicable service fees, and/or Hotel-specific fees in effect at the time of the Event.
Grand Hyatt Seattle is located conveniently in downtown Seattle within walking distance to Space Needle, Pike Place Market, and the shopping district. Take advantage of public transportation when you stay at the Grand Hyatt.
Travel
Grand Hyatt Seattle is located conveniently in downtown Seattle within walking distance to Space Needle, Pike Place Market, and the shopping district. Take advantage of public transportation when you stay at the Grand Hyatt.
TRANSPORTATION
Distance from Seattle-Tacoma International Airport: 15 miles.
The following transportation options are available from/to the airport.
- Taxi – 25 minutes (estimated $50.00 each way)
- Scheduled Airport Shuttles – 30 minutes (estimated $35.00 each way)
- Uber/Lyft – 25 minutes (estimated $30.00 each way)
- Link Light Rail – 40 minutes ($3.00 each way) - *Exit at Westlake Station, Grand Hyatt is 2 blocks southwest.
PARKING
The hotel offers convenient parking for guests and visitors. The hotel parking options include valet or self parking:
• Valet Parking: $55/night; No In & Out privileges included
• Self-Parking: $37/night; No In & Out privileges included
You can also self park at the nearby Hyatt Regency at $18/night with in/out privileges included.
Amy Davidoff, PhD, MS has a financial relationship (Independent contractor) with Amgen.
Rachel Yung, MD has no relevant financial relationships to disclose at this time.
Bridgette Hempstead has no relevant financial relationships to disclose at this time.
Petros Grivas, MD, PHD has a financial relationship (Independent contractor) with Merck, Bristol-Myers Squibb, AstraZeneca, EMD Serono, Seattle Genetics, Pfizer, Janssen, Mirati Therapeutics, Exelixis, Roche, Genentech, Dyania Health, Infinity Pharmaceuticals, QED Therapeutics, 4D Pharma PLC, Regeneron Pharmaceuticals, Astellas Pharma, Guardant Health, Urogen pharma, Gilead Sciences, Silverback Therapeutics; financial relationship (Grant or Contract) with Research funding to the institution: Pfizer, Clovis Oncology, Bavarian Nordic, Bristol-Myers Squibb, Debiopharm Group, Merck, QED Therapeutics, GlaxoSmithKline, Mirati Therapeutics, EMD Serono, G1 Therapeutics, Gilead Sciences.
Richard Goss, MD has no relevant financial relationships to disclose at this time.
Afsaneh Barzi, MD, PHD has no relevant financial relationships to disclose at this time.\
Hannah Linden, MD has a financial relationship (Grant or Contract) with GE, Sanofi, Veru, Zeno, Tolmar.
GHASSAN ABOU-ALFA, MD
Benjamin Anderson, Professor of Surgery and Global Health Medicine
Ellen Baker, MD, MPH
C. Anthony Blau
Sibel Blau, MD
Edward Briercheck, MD/PhD
Robert Carlson, MD
Elizabeth Chiao, M.D., M.P.H.
Farouk Dako, MD, MPH
Nancy Davidson, MD
Johan De Munter, RN, PgCert
Marianne Dubard-Gault, MD, MS
Narjust Duma, MD
JOSEPHINE FELICIANO, MD
Nazik Hammad, M.D., M.Sc., MEHP, FACP
Norrisa Haynes, MD, MPH, MSHP
Geraldine Jacobson, MD, MPH, MBA
Mark Lewis, M.D.
Ana Maria Lopez, MD, MPH
Michael Louella, BS
Manoj Menon, MD, MPH
Danny Milner, Jr, MD, MSc, MBA
Edith Mitchell, MD, MACP, FCCP, FRCP
Chadi Nabhan, MD MBA
Salim Nganzi, Mr
Joel Palefsky, MD
Aparna Parikh, MD
Manali Patel, MD, MPH, MS, FASCO
Shilpen Patel, Shilpen Patel, MD, FACRO FASTRO
Mark Pegram, MD
Joseph Rosales, MD
Rafael Santana-Davila, MD
Matthew Schabath, Matthew B. Schabath, PhD
Ravi Shrestha, Dr Ravi Bickram Shrestha PhD DIC ACGI FFBA
Rachna Shroff, MD
Chiranjiv Singh
Bhawna Sirohi, MBBS, FRCP
Dingle Spence, MBBS, Dip Pall Med, FRCR
Richard Sullivan
Lisa Tachiki, MD
Molly Tokaz
Joseph Unger
Dipesh Uprety, MD, FACP
Everett Vokes, MD
Michael Wagner, M.D.
Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA
Siddhartha Yadav, Siddhartha Yadav, MD, FACP
David Aboulafia, MD
Chandrikha Chandrasekharan, MBBS
Julie Gralow, MD
Natasha Hunter, MD
Shaji Kumar, MD
Chadi Nabhan, MD MBA
Howard (Jack) West, MD, Associate Professor, City of Hope Cancer Center, Los Angeles, CA
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is supported with independent medical education grants from the following companies:
Novartis Pharmaceuticals.
Janssen Scientific Affairs, LLC
Pfizer, Inc.
Merck Sharp & Dohme
AstraZeneca
BCRF Sponsorship
We would like to thank the Breast Cancer Research Foundation for sponsoring the Breast Cancer Disparities Session.
Available Credit
- 14.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 14.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 14.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 14.00 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
Notice to HCPs employed by the industry:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
Registration fees for SCHD22 increase on 4/15/22. Late registration fees apply.
Cancellation Policy
Refund Policy
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.